BRAIN Biotech AG (FRA:BNN)
2.220
-0.080 (-3.48%)
At close: Sep 9, 2025
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €48.50 million as of September 10, 2025. Its market cap has increased by 26.14% in one year.
Market Cap
48.50M
Enterprise Value
37.97M
Revenue
53.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.22
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 48.50M, a decrease of -67.52%. That is a compound annual growth rate of -11.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 48.50M | -37.46% |
Dec 30, 2024 | 77.56M | -3.01% |
Dec 29, 2023 | 79.96M | -37.33% |
Dec 30, 2022 | 127.59M | -37.20% |
Dec 30, 2021 | 203.18M | 13.16% |
Dec 30, 2020 | 179.55M | -7.93% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Feb 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 268.38B |
Siemens Aktiengesellschaft | 179.08B |
Deutsche Telekom AG | 147.97B |
Allianz SE | 134.37B |
Rheinmetall AG | 82.06B |
Siemens Energy AG | 71.89B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.73B |
Deutsche Bank Aktiengesellschaft | 58.53B |